
Cell & Gene: The Podcast
Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.
Podcasting since 2021 • 108 episodes
Cell & Gene: The Podcast
Latest Episodes
Rethinking Large Animal Models in Gene Therapy with Novartis' Ralf Schmid, Ph.D.
On this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Ralf Schmid, Ph.D., Associate Director of Preclinical Research at Novartis Biomedical Research, about the evolving use of large animal models in gene therapy development...
•
Episode 107
•
24:49

Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath
In this episode of Cell & Gene: The Podcast, George Magrath, CEO of Opus Genetics, shares with Host, Erin Harris, how the company is advancing gene therapies for inherited retinal diseases (IRDs), with a focus on LCA5, a rare and severe for...
•
Episode 106
•
20:13

Extracellular Vesicle Breakthroughs with Aegle Therapeutics' Dr. Gloria Matthews
In this episode of Cell & Gene: The Podcast, Host Erin Harris interviews Dr. Gloria Matthews, Chief Medical Officer of Aegle Therapeutics, a clinical-stage regenerative medicine company focused on developing therapies for rare and severe de...
•
Episode 105
•
15:58

Bridging Development and Regulation in CGT with Halloran Consulting Group's Monika Swietlicka
On this episode of Cell & Gene: The Podcast, Host Erin Harris welcomes Monika Swietlicka, Principal, Regulatory Strategy at Halloran Consulting Group to discuss the key regulatory challenges facing cell and gene therapy companies. Swietlick...
•
Episode 104
•
24:46

Harnessing AI and Synthetic Biology for Cell Therapies with Generate:Biomedicines' Dr. Alex Snyder
Host Erin Harris talks to Generate:Biomedicines' EVP of R&D, Dr. Alex Snyder about the convergence of AI, machine learning (ML), and synthetic biology in the development of next-generation therapies. They cover how AI is transforming drug d...
•
Episode 103
•
19:28

Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
